The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Finance

Lallemand Health Solutions is strengthening its strategic position in the microbiome field through CDMO operations
Finance

Lallemand Health Solutions is strengthening its strategic position in the microbiome field through CDMO operations

OCT 20, 2023
Kanvas Biosciences Acquires Federation Bio Assets to Scale Discovery, Development and Manufacturing
Clinical & Manufacturing

Kanvas Biosciences Acquires Federation Bio Assets to Scale Discovery, Development and Manufacturing

OCT 12, 2023
Clinical Microbiomics announces merger with CosmosID
Finance

Clinical Microbiomics announces merger with CosmosID

OCT 11, 2023
Evvy, Precision Women’s Health Startup focused on the Vaginal Microbiome, Announces $14M Series A
Finance

Evvy, Precision Women’s Health Startup focused on the Vaginal Microbiome, Announces $14M Series A

SEP 28, 2023
Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial
Clinical & Manufacturing

Bloom Science Announces Positive Topline Data from a Phase 1 Clinical Trial

AUG 18, 2023
Bactolife Raises EUR 30 million in Series A Financing
Finance

Bactolife Raises EUR 30 million in Series A Financing

AUG 8, 2023
Dutch government reserves €200 million for Holomicrobiome Institute
Finance

Dutch government reserves €200 million for Holomicrobiome Institute

JUL 5, 2023
Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich
Biotics and Supplements

Adare Pharma Solutions announces divestiture of postbiotics pioneer Adare Biome to dsm-firmenich

JUL 4, 2023
Exeliom Biosciences Announces Series A Extension and Final Closing with Total of €24 Million
Finance

Exeliom Biosciences Announces Series A Extension and Final Closing with Total of €24 Million

JUL 3, 2023
Pendulum Therapeutics Announces Strategic Partnership and $10M Investment from Fonterra
Finance

Pendulum Therapeutics Announces Strategic Partnership and $10M Investment from Fonterra

JUL 3, 2023
New biotech venture PHIOGEN, a spinoff of BCM’s TAILOR Labs
Finance

New biotech venture PHIOGEN, a spinoff of BCM’s TAILOR Labs

JUN 22, 2023